Earnings Releases
Quarterly 2024
Q4 & Full Year 2024 Earnings Conference Call
Annual
2018
Annual
2017
Annual
2016
Annual
2015
Annual
2014
Annual
2013
Annual
2012
Annual
2011
Annual
2010
Annual
2009
Annual
2008
Genomma’s second quarter sales grew +0.5%, or +5.5% excluding Argentina, reflecting a significant Argentine peso depreciation and a weak beverage season in Mexico. Importantly, the company’s profitability remained solid, with +4.4% EBITDA growth, margin expanding +89 bps to 23.8%, and a proforma net income increase of +16.6% (excluding non-cash FX related effects). These profitability levels and a 7-day improvement in cash conversion cycle drove a +64.6% free-cash-flow increase for the trailing twelve months. As the company navigates macroeconomic headwinds in 2025, we remain intently focused on executing our growth projects while maintaining an average EBITDA margin of 24% through our ongoing productivity program.
Marco Sparvieri
Chief Executive Officer
July 23, 2025
